channels are dynamic molecules that undergo rapid structural changes in response to the changing electrical field in the myocardium. Inherited mutations in SCN5A, the gene encoding the cardiac Na channel, provoke life-threatening cardiac arrhythmias, often by modifying these voltage-dependent conformational changes. These disorders (i.e., the long QT syndrome and Brugada syndrome) may serve as valuable models for understanding the mechanistic linkages between Na channel dysfunction and cardiac arrhythmias in more common, acquired conditions such as cardiac ischemia. In addition, the balance between therapeutic and adverse effects from Na channel blockade by antiarrhythmic compounds may be shifted by subtle alterations in Na channel function. This review examines recent studies that tie key loci in the Na channel primary sequence to its dynamic function, while examining the emerging themes linking Na channel structure, function, and pharmacology to inherited and acquired disorders of cardiac excitability.
Introduction
that drastically change their structural conformation on a sub-millisecond time scale in reVoltage-gated sodium (Na) channels are transmembrane proteins responsible for the rapid upsponse to the transmembrane electrical field, a process termed ''gating''. 4 As genomic strategies stroke of the cardiac action potential, and are therefore responsible for rapid impulse conduction increasingly link disorders in electrical excitability to cardiac Na channel mutations, functional studies through much of the myocardium. As such, cardiac Na channels are key molecular substrates in both of the ''diseased'' channels reveal pathologic gating defects. Whereas the salutary and toxic effects of inherited and acquired disorders of cardiac excitability. Na channel blockade as a general antianti-arrhythmic drugs hinge critically upon gating transitions, 5,6 progress in drug design will require arrhythmic strategy has proven to be a dual-edged sword, with significant proarrhythmic risks.
1 Howintegration of the developing picture of Na channel structure with a refined image of gating function. ever, current progress in resolving ion channel structure, function, and molecular pharmacology This review presents an emerging view of cardiac Na channel gating function and pharmacology. foreshadows precise strategies to modify favorably Na channel function and cardiac excitability.
Structure-function relationships will be used as a scaffold to discuss mechanisms of arrhythmogenesis A crystal structure is now available for a potassium (K) channel from Streptomyces lividans, 2 and due to inherited Na channel mutations, as well as pro-arrhythmic effects of Na channel-blocking antihigh-resolution structural data are even becoming available for small segments of the Na channel.
3 At arrhythmic agents. As the discussion and citations The S4 segments in each of the four homologous domains contain positively charged lysine and arginine residues that detect changes in the transmembrane field. The bold S5-6 linker sequences are "P-segments" that line the outer pore. The III-IV linker plays a major role in fast inactivation. Individual amino acid residues discussed in the review are numbered according to the original rat skeletal muscle clone. 13 B: Simplified scheme of the Na channel gating conformational changes in response to membrane depolarization. Activation and fast inactivation occur nearly simultaneously, such that channels sometimes reach the fast inactivated state (I fast ) without opening (closed-state inactivation). Sustained depolarization induces channels to occupy stable, slow inactivated states (I slow ).
will be selective, the reader is referred to more to define specific amino acid residues involved in voltage-dependent gating function. 9 Figure 1(B) thorough treatments of related topics including Na channel regulation by second messengers and shows the principle gated states occupied by Na channels as the cell membrane is depolarized. Upon enzymes, details of cation permeation, and moddepolarization, channels undergo a process termed ulation by subsidiary ( ) subunits. [7] [8] [9] [10] ''activation'', involving the concerted, outward movement of all four charged S4 segments that leads to opening of the channel pore.
14,15 At the Sodium channel gated states: linking same time, depolarization triggers the initiation of structure to function ' 'fast inactivation'' [ Fig. 1(B) ], a distinct form of channel closure from which opening does not occur. In contrast to the number and diversity of voltageLike channel opening, inactivation is tied to the gated K channels, the voltage-gated Na channels outward movement of the S4 sensors, but primarily are relatively small in number and are highly hothose in domains III and IV (D3S4, D4S4: notation mologous in amino acid sequence. Of the 11 isoused throughout the text). [16] [17] [18] Consistent with this forms identified to-date, eight have been dual role for the S4 voltage sensor is the observation functionally characterized (see recent review by that activation and fast inactivation gating are Catterall, 2000) 9 and reside in neuronal tissue, tightly coupled, [16] [17] [18] [19] [20] and proceed more or less simskeletal muscle, and cardiac muscle. Our underultaneously. 21 Hence, any given Na channel may standing of Na channel structure and gating funcopen prior to inactivating, or alternatively, may tion has escalated with cloning and expression of inactivate without ever opening [so-called ''closedthe channel protein.
11 While many of the original state inactivation'', Fig. 1(B) ]. 22 As discussed below, studies correlating structure and function used skelclosed-state inactivation may profoundly influence etal muscle or neuronal isoforms, the themes that the action of anti-arrhythmic compounds, especially emerged proved to be generalizable to the cardiac when modified by inherited mutations. 23 isoform.
Fast inactivation also critically involves the III-IV The tetrodotoxin ''insensitive'' human cardiac Na linker [ Fig. 1(A) ], [24] [25] [26] which may function as a ''lid'' channel (hH1), encoded by the gene SCN5A, 12 is that occludes the pore, 27, 28 binding to sites situated composed of a principal ( ) subunit that includes on or near the inner vestibule. [29] [30] [31] [32] [33] [34] [35] [36] Studies of ''gating four homologous subunits or domains [numbered current'', produced by the movement of charged I-IV, Fig. 1(A) ], attached to one another by cytoresidues through the membrane electric field, are plasmic linker sequences. Over the last decade, siteproviding new insights into the relationship bedirected mutagenesis has been utilized in concert tween S4 motion and the inactivation ''lid''. Gating currents are slowed or ''immobilized'' by fast inwith patch-clamp electrophysiologic measurements Figure 2 Inherited mutations in the cardiac Na channel. The topology of the Na channel is shown in the same style as Figure 1 , and indicates mutations (numbering follows the human cardiac Na channel, hH1) linked to the Long QT syndrome and Brugada syndrome. Mutations tend to cluster in and around the S4 segments, the III-IV linker, and the C-terminus, consistent with the key roles of these loci in channel gating function. activation, 19 suggesting the possibility that binding permeation pathway. 48 Studies of induced disulfide bridges in the outer pore of the Na channel also of the III-IV linker may lock the S4 sensors in an reveal a flexible structure, 49, 50 suggesting an anaoutward position. However, recent studies indicate logous relationship may exist between the pore that the D4S4 gating charge is immobilized by and slow inactivation. 46 A channel engineered to inactivation independent of whether the III-IV include dual P-segment cysteine substitutions ( Fig.  linker ' 'lid'' is bound, 37 suggesting additional gating 1: K1237C-W1531C) forms an internal disulfide mechanisms must underlie charge immobilization.
bond that occludes the pore when exposed to an oxidizing catalyst. 49 Disulfide bond formation was . 46 It was Whereas fast-inactivated Na channels recover therefore postulated that the two P-segment cyrapidly (within 10 ms) during the hyperpolarized steinyls are approximated more closely in the interinterval between stimuli, upon prolonged demediate (I M ) inactivated state than in either the polarization Na channels progressively enter ''slow'' fast-inactivated (I F ) or slower-inactivated (I S ) states inactivated states [I Slow , Fig. 1(B) ]. 38 These more [ Fig. 3(B) ]. 46 The emerging picture of the Na channel stable, non-conducting states have diverse lifetimes pore incorporates a high degree of conformational ranging from hundreds of milliseconds to many flexibility during both gating and permeation, and seconds.
39, 40 An ''intermediate'' kinetic component may even suggest analogies between Na channels of slow inactivation (I M ) develops in cardiac Na and enzymes. 52 channels with a time course relevant to the duration Just as the S4 segments ''transduce'' the changing of the cardiac action potential (100 s of milmembrane potential to the fast-inactivation gating liseconds). 41, 42 Although the structural destructures, the D4S4 sensor may have an analogous terminants of slow inactivation are less well defined role in slow inactivation. Here again, structurethan fast inactivation, both site-directed mutations function motifs in the K channel parallel those in and chimeric analyses suggest a key role for the Pthe Na channel. Recent studies utilizing patchsegments, [43] [44] [45] [46] linker sequences between the S5 and clamp recording and voltage-clamp fluorometry re-S6 segments in each domain that bend back into veal that the K channel outer pore interacts directly the membrane and line the outer pore [Figs 1(A), with the S4 voltage sensor during slow (C-type) 2].
inactivation. 53 In Na channels, slow inactivation Slow ''C-type'' inactivation in K channels involves gating is amplified by sulfhydryl modification of a a dynamic rearrangement of the outer pore struccysteine engineered at the third outermost arginine residue in D4S4 [R1456C; Fig. 1(A) ]. 54 This effect ture 47 that even alters the characteristics of the Figure 3 Disulfide bond formation in the outer pore catalyzed by 100  Cu(phe) 3 . A: I Na was generated in Xenopus oocytes expressing K1237C-W1531C channels at a pulse rate of 0.05 Hz. The pulse duration (abscissa) ranged from 3 ms to 5 s. The rate at which peak I Na decreased reflects the rate of interdomian disulfide bond formation (ordinate was antagonized by alanine substitution in the potential plateau [ Fig. 4(A) ]. This excess inward current, essentially a gain of Na channel function, domain I P-segment [ Fig. 1 (A), W402A)], 54 a subdelays cellular repolarization and predisposes stitution known to inhibit the intermediate compatients to polymorphic ventricular tachycardia. ponent of slow inactivation. 55 
These results
Surprisingly, the size of this sustained current is motivate future studies to define functional linkages miniscule (>0.5-2%) compared to the rapid inward between voltage-sensing, slow inactivation, and the Na current that develops immediately upon dedynamic structure of the Na channel pore.
polarization (''peak I Na ''). [58] [59] [60] Nonetheless, linkage between this sustained current, action potential prolongation, and pro-arrhythmic activity has been Inherited cardiac Na ''channelopathies'' validated in quantitative modeling 61 that illustrates the highly non-linear relationship between Na modify gating function channel function and cardiac excitability. The Na channel normally opens only briefly Consistent with the role of the III-IV linker in (>1 ms), and then ''fast inactivates'' as the action fast inactivation (Fig. 1) , the first reported LQT3 potential commences, producing a large inward mutation was a deletion of three residues in this current that rapidly extinguishes. Once inactivated, region (1505-1507 KPQ, Fig. 2 ). 57 Three other channels normally cannot reopen until the memmutations reside near the cytoplasmic face of the brane potential hyperpolarizes (during diastole), alchannel (N1325S, R1644H, T1645M) 57,58,62 and lowing a period of recovery. Mutations in the cardiac may influence the motion or binding of the III-IV Na channel linked to an autosomal dominant form linker during fast inactivation. Mutations in other of the long QT syndrome (''LQT3'', Fig. 2) . 56 produce regions of the Na channel that are critical to fast electrocardiographic QT interval prolongation and inactivation elicit LQT3.Two SCN5A mutations a peculiar polymorphic ventricular tachycardia reside in D3S4 and D4S4 (T1304M, R1623Q, (Torsades de Pointes). These mutations invariably Fig. 2 ), 62,63 the voltage sensors linked closely to disrupt fast inactivation [57] [58] [59] and allow repeated inactivation. 18 In addition to ''destabilizing'' inreopening during sustained depolarization, evoking activation (i.e. allowing reopening of inactivated channels), open R1623Q channels exhibit a slowed a small, persistent Na current during the action rate of entry into the fast-inactivated state, causing the C-terminus influences fast inactivation remains uncertain; studies of multiple simultaneous charge a ''gain of function'' by prolonging the Na current decay [see Fig. 5(A) ]. 65, 66 neutralizations in the C-terminus do not elicit a more severe or additive effect, 67 suggesting that this A highly conserved acidic domain in the C-terminus also appears to be a ''hot-spot'' for LQT3 acidic region does not participate in fast inactivation directly as a charged ''binding particle''. Rather, mutations (Fig. 2) . While two charge-altering LQT3 mutations in this region (E1784K, 1795insD) 42, 67 mutations in the C-terminus may impose allosteric effects on more proximal gating domains. evoke small, sustained currents similar to KPQ, a third charge deletion (D1790G) alters the voltage-A distinct class of idiopathic ventricular arrhythmias, collectively known as the ''Brugada syndependence of inactivation but may not evoke sustained Na current. 68 Computational analysis sugdrome'', 70 trace their origin to recently-identified SCN5A mutations. Unlike patients with the long gests that D1790G alters the kinetics of Na channel inactivation at membrane potentials near the action QT syndrome, these patients manifest distinctive electrocardiographic features that include right potential plateau, thereby changing the balance of other currents to evoke action potential probundle branch block and elevation of the ST segment in leads V1 to V3. The mutations traced to longation. 69 The structural mechanism whereby Brugada syndrome seem to arise at scattered loci, clinical phenotype) 42 due to the relatively brief diastolic interval. Moreover, recent studies of the Bruand initial efforts to characterize these disorders using heterologous expression yielded diverse and gada T1620M mutant reveal analogous enhancement of the I M slow inactivation compuzzling results. 71 Identified frameshift and splicedonor mutations ( Fig. 2 ; a premature stop codon ponent. 79 Taken together, these results may suggest that loss-of-function in the Na channel is, after all, and ''AA'' nucleotide insertion) would render the channel entirely non-functional, 72 in contrast to the a consistent mechanistic feature of the Brugada syndrome, and raise the possibility that enhanced ''gain-of-function'' effects seen in LQT3. Similarly, a Brugada syndrome mutation in the domain III slow inactivation is a general pro-arrhythmic mechanism in idiopathic VF. P-segment (R1432G) eliminated the Na current entirely, 73 possibly related to its location in the pore. Inspection of Figure 2 suggests that SCN5A loci linked to Brugada syndrome are scattered compared Two additional Brugada syndrome mutations in the III-IV interdomain linker (R1512W) and the C to those associated with LQT3. However, there is an intriguing non-random ''clustering'' of Brugada terminus (A1924T) 74 did not eliminate channel function entirely, but shifted the voltage-desites adjacent to several LQT3 loci. For example, T1620M (Brugada) resides on the external linker pendence of steady-state inactivation to more negative membrane potentials, thereby reducing the between S3 and S4 in domain IV, only three residues C-terminal to the outermost S4 arginine (R1623Q; availability of channels to open (a ''loss-of-function''). Conversely, studies of Brugada mutation LQT3). The observed gating effects of R1623Q on fast inactivation 65,66 and T1620M on both fast and (T1620M) in Xenopus oocytes revealed opposite results: a positive shift in the voltage-dependence slow inactivation 75, 79 are consistent with the structure/function data (discussed above) supporting the of inactivation and hastened recovery from inactivation, 72 consistent with an increase in Na role of D4S4 in both gating processes. 16,17,54 Analogous clustering of LQT3 and Brugada syndrome channel availability. At the same time, studies of T1620M in cultured mammalian cells found mutations appears in the III-IV linker (Fig. 2) . While these mutations typically disrupt inactivation hastened development of fast-inactivation 75 and slowed recovery from fast inactivation, 75, 76 con-(LQT3), a recently identified Brugada syndrome mutation (R1512W) slowed recovery from insistent with a loss-of-function. Complicating the picture further are recently identified SCN5A mutactivation, 73, 74 and lies only five residues away from the KPQ LQT3 deletion. A number of LQT3 and ations that should produce entirely non-functional channels, yet appear to cause only isolated cardiac Brugada mutations also lie side by side in the C terminus and influence both fast and slow inconduction defects.
77
Further insight into the linkage between lossactivation (Fig. 2) . The surprisingly diverse effects of these vicinal mutations emphasize the importand gain-of-function and these arrhythmia syndromes has emerged from analysis of a unique ance of future studies aimed at defining the 3-dimensional protein structure. C-terminal SCN5A mutation that causes affected individuals to manifest heart-rate-dependent features of both LQT3 and Brugada syndrome: the QT interval is prolonged at slow heart rates, and distinctive ST-segment elevations occur with exLoss of Na channel function: a general ercise. 42, 78 Consistent with the notion that LQT3 is pro-arrhythmic mechanism?
elicited by a gain of function, and Brugada syndrome by loss of function, the mutation (1795insD) Inquiry into the mechanisms whereby loss of Na channel function may induce ventricular fibrillation has opposite effects on two distinct kinetic components of Na channel inactivation (fast and slow). 42 predates the Brugada syndrome-Na channel linkage studies, 80,81 and was motivated partly by the proLike many other LQT3 mutations, 1795insD disrupts fast inactivation, causing sustained Na curarrhythmic consequences of Na channel blockade in the CAST trial. 1 In short, the epicardial myocardial rent throughout the action potential plateau [ Fig.  4(A) ], prolonging cardiac repolarization at slow cell action potential duration is much more sensitive to factors reducing I Na than the endocardial action heart rates. At the same time, 1795insD augments the intermediate kinetic component of slow inpotential, due to a prominent transient outward potassium current (I to ) that counterbalances I Na in activation [ Fig. 4(B) , denoted ''I M '' in Fig. 3 ]. This gating effect slows the recovery of Na channels the epicardium. Hence, conditions that significantly reduce I Na (i.e. Brugada syndrome mutations 82, 83 or between stimuli, causing loss-of-function mainly at rapid heart rates (consistent with the 1795insD cardiac ischemia 84,85 ) may selectively shorten the Figure 5 R1623Q channels exhibit enhanced sensitivity to lidocaine. 23 Left, A: I Na recorded from Xenopus oocytes expressing wild-type and R1623Q Na channels. Cells were depolarized from −100 to −20 mV in the presence (dotted line) and absence (solid line) of 200  lidocaine. Lidocaine hastened the decay of I Na , and also reduced R1623Q peak I Na to a greater extent. B: I Na decay rate ( 50 , ms) before (open bars) and after (solid bars) exposure to lidocaine, and C. paired data comparing the fractional reduction of peak I Na due to lidocaine. The drug suppressed peak I Na and hastened I Na decay to a greater extent in R1623Q than wild-type ( * P<0.05). Panels A-C are from Fig. 1, Kambouris et al., 2000 . Right: An allosteric effector scheme for lidocaine action that involves state-dependent binding to closed and inactivated states, while adhering to principles of microscopic reversibility. Upon depolarization, by virtue of higher affinity for the inactivated state(s) than closed state(s), energy conservation principles require that drug-bound channels (those residing in the "Lido-Closed" state) are more likely to inactivate than drug-free channels (those residing in the "Closed" state). Hence, the bound antiarrhythmic drug functions as an "allosteric effector" to promote inactivation gating. 64 duration of the epicardial action potential. This particularly since the pro-arrhythmic risk was exaggerated by ischemia. 1 It is noteworthy that Na condition creates a temporal imbalance between endocardial and epicardal repolarization, and such channel blocking agents exacerbate the ECG pattern in known cases of Brugada syndrome, 90 ''unmask'' electrical heterogeneity may underlie the ST segment elevation and pro-arrhythmic manifestations the syndrome in patients who have SCN5A mutations and transiently exhibit Brugada ECG maof the Brugada syndrome. 82, 83 Does the linkage between inherited or acquired Na nifestations, and in some cases evoke both the Brugada phenotype and ventricular fibrillation de channel dysfunction and risk for ventricular arrhythmias provide insight into the pro-arrhythmic ponovo. 91, 92 tential of antiarrhythmic agents? Studies identify pro-arrhythmic effects (rate-dependent slowing and facilitated re-entry) of Na channel blockade in fibers from the epicardial border zone of the infarcted A ''mobile'' drug-binding pocket for heart. 86, 87 Corroborating these findings are studies of
antiarrhythmic drugs
Na channel function in cells isolated from the epicardial border zone of he 5-day infarcted canine Further insights into the pro-arrhythmic features of Na channel blockade have arisen from siteheart. 88, 89 These studies reveal slowed Na channel recovery from inactivation (Pu et al., their Fig. 5   89 ), directed mutagenesis of pore-lining domains. Antiarrhythmic drugs ''block'' Na channels at consistent with enhancement of the intermediate kinetic component of slow inactivation (I M ). More->100-fold lower concentrations when depolarized, suggesting antiarrhythmic drug affinity is gatingover, enhanced use-dependent lidocaine block was also identified in the border zone cells, 89 consistent dependent (the ''modulated receptor hypothesis''). 5,6,93,94 Hence, it is not surprising that amino with the emerging evidence that slow inactivation may facilitate use-dependent Na channel blockade acid residues crucial to drug binding and channel gating overlap to some degree. For example, alanine (discussed below). This mechanism may relate to the toxicity of particular Na channel blockers in CAST, substitution of D4S6 residues ( Fig. 6; F1579 (Fig. 6; N434, L437 ) also reduce drug Whereas the inherited SCN5A mutations provide affinity, suggesting the D1S6 and D4S6 segments valuable insights into Na channel gating mechtogether may form a domain interface site for antianisms, these mutant channels prove useful as arrhythmic drug binding. 97, 98 At the same time, ''probes'' for investigating the molecular pharmutation of F1579 disrupts fast inactivation macology of antiarrhythmic drugs, and also provide gating, 29, 30 and substitution of the D1S6 residue insight into how particular agents may be beneficial, N434 markedly alters both fast and slow inor even harmful, in patients who carry mutations. activation gating. 97 The extent to which these S6 Na channel blockers may be particularly useful in loci influence antiarrhythmic drug affinity by their managing patients with LQT3 disorders. 106,107 The effects on inactivation gating is difficult to resolve. sustained inward currents through Na channels that However, the dual role of S6 residues involved harbor LQT3 mutations are potently inhibited by in drug binding and inactivation gating may be lidocaine and its analogues, 58,108 a pharmacologic more than coincidental. Recent spin labeling studies effect that may serve to hasten repolarization in of the putative S6 (''M2'') domain in the KcsA patients with LQT3 disorders. 109 Initial studies of channel suggest the alpha helical segment undrug action posited that lidocaine may avidly bind dergoes a 20°twist during gating. 99 If analogous to the open LQT3 channel pore, or may even ''repair'' movements occur in Na channel S6 segments, the the fast inactivation of open channels. 65,110 However, particular residues mediating drug binding may studies of the R1623 LQT3 mutant reveal an unundergo positional changes during membrane deanticipated mechanism for lidocaine action on suspolarization that alter the drug binding site and tained current. 23 Parch-clamp experiments using contribute to gating-dependent binding affinity.
heterologously-expressed mutant channels revealed In fact, studies examining diverse amino acid that not only the sustained current component, but substitutions in Na channel D4S6 and D1S6 loci also the peak I Na was unusually sensitive to lidocaine suggest that the physicochemical properties (aro-[ Fig. 5(A) ]. Further studies in drug-free conditions maticity, polarity) of the residues correlate with revealed that ''closed-state'' inactivation of R1623Q block affinity only when the channel is inactivated. channels was actually increased [see Fig. 1(B) ], 23 in Hence, the channel inactivation process may alter contrast to the more obvious mutation-induced dis-S6 side chain orientations in a manner that faruption in open-state inactivation. 65 Using a quancilitates drug binding. 97, 100 titative Markov model, it was demonstrated that Experiments with permanently charged lidocaine state-dependent lidocaine affinity could further augderivatives (i.e. QX-314) suggest that the hydroment closed-state inactivation through an allosteric philic moiety approaches its receptor in the pore effector mechanism [ Fig. 5(B) ], 23 providing a parfrom the intracellular (cytoplasmic) side. 101, 102 This simonious explanation for lidocaine suppression of implies that the putative drug binding residues in both peak I Na and the sustained R1623Q inward cur-S6 lie intracellular to the cation ''selectivity filter'', rent. Notably, the same model was sufficient to rewhich is formed by the ''DEKA'' residues contributed produce observed effects of lidocaine on sustained by the P-segments of each domain (Fig. 6) . 103 HowNa currents induced by other LQT3 mutations (i.e., ever, P-segment residues within the ''DEKA'' ring, KPQ), 23 suggesting an allosteric interaction beand even those immediately adjacent to the ring, tween lidocaine and the closed-state inactivation are accessible only from the outside. 104 Hence, the mechanism may be generally applicable. selectivity filter residues appear to ''bridge'' the inner While Na channel blockers may have beneficial and outer pore regions (Fig. 6) , and limit external effects on the sustained current induced by LQT3 access (and escape) of hydrophilic compounds. Admutants, the enhanced sensitivity of R1623Q peak ditionally, the P-segment filter residue in domain I Na to lidocaine [ Fig. 5(A) ] raises concerns regarding III ( Fig. 6; K1237 ) is positively charged, and repels the pro-arrhythmic potential of Na channel blockade the ionizable amino group of lidocaine. 105 These in this setting, by reducing the epicardial Na current findings suggest proximity between the putative (i.e. Brugada syndrome). In this context, it was redrug receptor loci in S6 and the P-segment secently observed that flecainide, a potent Na channel lectivity filter regions (Fig. 6) , 105 and may provide blocker, elicited ECG ST elevation in a number of a rationale for antiarrhythmic drug-induced conpatients carrying LQT3 mutations. 111 If the closedformational changes involving the outer P-segment state inactivation gating characteristics of R1623Q are recapitulated in other Na channels carrying (see below, ''Use-dependent Na channel block''). studies suggest that these fast-inactivation gating effects on lidocaine action may be indirect, or allosteric in nature. By utilizing MTS reagents and a rapid perfusion system to covalently modify an engineered cysteine in the III-IV linker ''latch'' [F1304C, Fig.  1(A) ], it was possible to monitor the position of the latch at a time scale relevant to fast-inactivation gating. 116 Lidocaine accelerated depolarization-dependent ''binding'' of the latch cysteine to its receptor, suggesting that the drug promoted fast-inactivation gating upon initial depolarization, 116 consistent with the postulated drug-induced facilitation of closedstate inactivation in LQT3 channels. 23 However, upon subsequent repolarization, recovery of drugbound channels was typically slow (100 s of milliseconds), but recovery of the latch residue was rapid. Hence, lidocaine block either directly or in- substantially reduce the maximal gating charge (I g ) associated with channel depolarization, and also decrease the slope of the gating-charge voltage dependence. 117,118 Moreover, site 4 toxins (that specifically inhibit movement D4S4 sensor) have an additive effect with lidocaine to suppress the LQT3 mutations, the associated pharmacologic sensitivity may at once engender both a therapeutic maximal gating charge, further suggesting that lidocaine does not effectively ''stabilize'' the fast benefit (via sustained current suppression) and proarrhythmic risk (due to peak I Na suppression). In this inactivation gate. 118 Taken together, the studies suggest that lidocaine analogues may alter closedcontext, it was recently shown that the 1795insD mutation, linked to both the Brugada and LQT3 synstate inactivation by influencing the voltage sensors coupled to inactivation gating. Recent studies dromes, exhibits pronounced closed-state inactivation.
112 Peak 1795insD I Na was four-fold more examining the linkage between S4 motion and closed-state inactivation 119 lend support to this sensitive to Na channel blockade by procainamide compared to wild-type channels, 112 and propostulate. MTSET modification of a cysteine substituted for the outermost arginine [ Fig. 1(A) ; cainamide worsened the clinical phenotype in affected patients. 78 R663C] in D2S4 shifts the voltage-dependent behavior of the S4 segment to more hyperpolarized A direct interaction between Na channel blockers and the fast-inactivated conformational state would potentials, and also slows its outward movement during depolarization. These effects on the acreadily explain how augmented closed-state inactivation potentiates drug action. In fact, an intertivation sensor paradoxically cause the channel to exhibit an unusual degree of closed-state action between lidocaine and fast inactivation was originally postulated from data showing enzymatic inactivation. Whether antiarrhythmic drugs can inhibit movement of the S4 segments in an disruption of fast inactivation reduces lidocaine block, 113, 114 and was supported by later studies showanalogous direct manner, or alternatively through an allosteric (indirect) mechanism, remains uning mutagenic disruption of the III-IV linker also reduces lidocaine block. 115 However, more recent certain. edly increased use-dependent block sensitivity to Use-dependent Na channel block, flecainide (compared to wild-type channels), but slow-inactivation, and the P-segments not lidocaine. 121 The mutation resides in the Cterminus, a locus not previously associated with Na The studies discussed above provide insight into the sensitivity of Na channels to blockade that channel blockade, so the means whereby D1790G selectively alters the channel sensitivity to useensues immediately upon depolarization (''firstpulse'' block), which relates primarily to block that dependent flecainide block is unknown. Studies of lidocaine blockade during a number develops during a stimulus delivered after a long diastolic pause. Additional mechanisms may be of interventions (mutations, cation substitutions, subunits) that modify slow inactivation 54, [122] [123] [124] involved in modulating drug affinity that develops during repetitive ''trains'' of action potentials, and support an early proposal; 125, 126 that slow recovery of drug-bound channels between depolarizing stimpersists long after the channel is repolarized (''usedependent'' block). 120 For LQT3 patients who carry uli involves an interaction between the drug and slow-inactivated conformational states. Recent the D1790G mutation, flecainide hastens cardiac repolarization while lidocaine has no effect. 107 This studies 127 utilized an engineered cysteine in the domain III, P-segment [ Fig. 1(A) ; F1236C] as disparity is manifest in studies of heterologously expressed D1790G channels, which reveal marka ''sentinel'' for slow-inactivated motion of P-segments, and demonstrated state-dependent ac- polarizations [ Fig. 7(A,B) 
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